Enalapril mitigates senescence and aging-related phenotypes in human cells and mice via pSmad1/5/9-driven antioxidative genes
eLife · 2025
DOI: 10.7554/elife.104774 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, 2025. Verfasst von Wencong Lyu und 10 weiteren Autor:innen. Beteiligte Einrichtung: The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Enalapril, Cellular Senescence, Aging, Antioxidants. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.
Abstract (Originalsprache)
Aging increases the risk of a myriad of chronic diseases, which are expensive and difficult to treat owing to their various risk factors. Repurposing existing medications has accelerated the development of therapies aimed at slowing aging. In this study, using IMR90 cells and aged mice, we revealed that enalapril, a drug widely prescribed for hypertension, can improve both cellular senescence and individual health. Mechanistically, phosphorylated Smad1/5/9 act as pivotal mediators of the anti-senescence properties of enalapril. It stimulates downstream genes involved in cell cycle regulation and antioxidative defenses, facilitating cell proliferation and diminishing the production of reactive oxygen species (ROS), thus increasing the antioxidative ability of enalapril. At the organismal level, enalapril has been shown to bolster the physiological performance of various organs; it notably enhances memory capacity and renal function and relieves lipid accumulation. Our work highlights the potential of enalapril to augment antioxidative defenses and combat the effects of aging, thereby indicating its promise as a treatment strategy for aging-associated diseases and its use for healthy aging.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The MOE Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Peking University, Beijing, China.
- Kunming Institute of Zoology, Chinese Academy of Sciences, Kunming, China.
- Zhanjiang Institute of Clinical Medicine, Central People's Hospital of Zhanjiang, Guangdong Medical University, Zhanjiang, China.
ORCID-Profile: Wencong Lyu, Haochen Wang, Chao Zhang, Yiting Guan, Wei Tao
Förderung
- National Key Research and Development Program of China
Zitieren
APA
Lyu, W., Wang, H., Du, Z., Wei, R., He, J., Meng, F., Bi, J., Zhang, L., Zhang, C., Guan, Y., & Tao, W. (2025). Enalapril mitigates senescence and aging-related phenotypes in human cells and mice via pSmad1/5/9-driven antioxidative genes. eLife. https://doi.org/10.7554/elife.104774
Vancouver
Lyu W, Wang H, Du Z, Wei R, He J, Meng F, et al. Enalapril mitigates senescence and aging-related phenotypes in human cells and mice via pSmad1/5/9-driven antioxidative genes. eLife. 2025. doi:10.7554/elife.104774
BibTeX
@article{Lyu2025,
author = {Lyu, Wencong and Wang, Haochen and Du, Zhehao and Wei, Ran and He, Jianuo and Meng, Fanju and Bi, Jinlong and Zhang, Lijun and Zhang, Chao and Guan, Yiting and Tao, Wei},
title = {Enalapril mitigates senescence and aging-related phenotypes in human cells and mice via pSmad1/5/9-driven antioxidative genes},
journal = {eLife},
year = {2025},
doi = {10.7554/elife.104774}
}
EUVIMED